Clinical Oncology
Volume 19, Issue 5 , Pages 289-301, June 2007

Is the α/β Value for Prostate Tumours Low Enough to be Safely Used in Clinical Trials?

  • A. Daşu

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: A. Dasu, Department of Radiation Physics, Norrland University Hospital, 901 85 Umeå, Sweden. Tel:+46-90-785 27 84; Fax:+46-90-785 15 88.

Department of Radiation Physics, Norrland University Hospital, 901 85 Umeå, Sweden

Received 31 October 2006; received in revised form 22 January 2007; accepted 5 February 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(07)00518-3

doi:10.1016/j.clon.2007.02.007

Clinical Oncology
Volume 19, Issue 5 , Pages 289-301, June 2007